The clinical prognostic significance of CD44 in patients with gastric cancer has not been reported through the UACLAN database, so we attempted and found that the expression of CD44 was not related to the patient’s age or sex but was related to TNM stage, tumour size, degree of invasion, degree of differentiation and lymph node metastasis. This evidence concerns the gene CD44 and gastric cancer.